Deals
AI biotech founded by ex-Google CEO Eric Schmidt is raising $150 million
Hologen, a secretive AI startup co-founded by former Google CEO, is looking to raise $150 million.
Every story of January 2026, newest first. How AI is changing drug discovery, clinical trials, manufacturing and regulation.
Deals
Hologen, a secretive AI startup co-founded by former Google CEO, is looking to raise $150 million.
Safety
For many organizations, the workload has become too large for manual review alone. AI and automation are stepping in, not to replace the human element, but to restore focus to it.
Industry
As OpenAI and Anthropic move deeper into healthcare, experts say AI chatbots are becoming the new front door to medicine. This shift is shaking things up for some health tech startups, redefining the patient-provider…
Regulation
FDA cleared an AI tool from Aidoc that can detect multiple conditions from a single CT scan.
Drug Discovery
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley’s most influential VCs.
Regulation
The FDA delayed reviews of two drugs chosen for the Trump administration’s new fast-track program after agency scientists flagged safety and efficacy concerns
Industry
This year will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here four predictions.
Regulation
As “human-on-the-loop” AI reaches medical offices, new concerns are coming to the forefront.
Drug Discovery
At the J.P. Morgan Healthcare Conference in San Francisco, the AI drug discovery pitch is familiar: shrink timelines, automate bottlenecks, take a process that spans a decade-plus and billions of dollars and compress…
Drug Discovery
NVIDIA and Lilly are putting together “a blueprint for what is possible in the future of drug discovery,” NVIDIA founder and CEO Jensen Huang told attendees at a fireside chat Monday with Dave Ricks, chair and CEO of…
Drug Discovery
At JPM, Nvidia unveiled partnerships with Eli Lilly, Thermo Fisher and others that show how the chipmaker is pushing its AI beyond models and into the core infrastructure of drug discovery and research labs. The moves…
Industry
Precision medicine offers a path for healthcare to become more proactive, more personalized, and more effective for every individual with a far more sustainable cost curve.
Regulation
In this edition of STAT Health Tech: FDA’s deregulatory push on AI and wearables, OpenAI announces ChatGPT Health, and more.
Regulation
The FDA will ease regulation of digital health products, aiming to deregulate AI and promote its widespread use.
Drug Discovery
Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat
Clinical Trials
Big Pharma companies are still betting big on AI, with major players pouring resources into agent platforms. The goal: unify fragmented data, streamline operations from clinical trials to sales, and enable more…
Drug Discovery
Days after going public on the Hong Kong Stock Exchange, Insilico Medicine has struck a multi-year oncology drug discovery partnership with France’s Servier worth up to $888 million. The collaboration will focus on…
No stories match these filters.
Subscribe on YouTube, or get an email the day each new lesson goes live.
Ask ai2hired
Answers from this site only, with the pages they come from.
Hi! I can help with the free course: lessons, seasons, career paths, workbooks, credentials, the free tools and your account.
AI answers can be wrong: check the linked page. Not stored. Need a person? info@ai2hired.org